Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy

Journal of Controlled Release

Volumn 210, Issue , 2015, Pages 217-229

  Moles, Ernest ^a,b,c   Urbán, Patricia ^a,b,c   Jiménez Díaz, María Belén ^d   Viera Morilla, Sara ^d   Angulo Barturen, Iñigo ^d   Busquets, Maria Antònia ^c,e   Fernàndez Busquets, Xavier ^a,b,c  

^a INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d GLAXOSMITHKLINE   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Immunoliposomes; Malaria; Nanomedicine; Plasmodium; Targeted drug delivery

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; CELL MEMBRANES; CELLS; CYTOLOGY; DISEASES; ENCAPSULATION; ENZYME ACTIVITY; ENZYME INHIBITION; LIPOSOMES; MEDICAL NANOTECHNOLOGY; MONOCLONAL ANTIBODIES; PHOSPHOLIPIDS;

CROSSLINKER CONCENTRATION; ENCAPSULATION EFFICIENCY; IMMUNOLIPOSOMES; MALARIA; PLASMODIUM; PLASMODIUM FALCIPARUM; PRIMARY AMINO GROUPS; TARGETED DRUG DELIVERY;

BLOOD;

CHLOROQUINE; GLYCOPHORIN A; IMMUNOLIPOSOME; MONOCLONAL ANTIBODY; NANOCARRIER; POLYCLONAL ANTIBODY; PRIMAQUINE; ANTIBODY; ANTIMALARIAL AGENT; CARRIER PROTEIN; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; LIPOSOME; MAHRP-1 PROTEIN, PLASMODIUM FALCIPARUM; OLIGOPEPTIDE; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL FRACTIONATION; CELL METABOLISM; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HALF LIFE TIME; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIPID BILAYER; LIPOSOMAL DELIVERY; MALARIA CONTROL; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MALARIA, FALCIPARUM; METABOLISM; PARASITOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CARRIER PROTEINS; CHLOROQUINE; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; FEMALE; HUMANS; LIPOSOMES; MALARIA, FALCIPARUM; MICE, TRANSGENIC; OLIGOPEPTIDES; PLASMODIUM FALCIPARUM; PRIMAQUINE; PROTOZOAN PROTEINS;

EID: 84930660625     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.05.284     Document Type: Article

References (65)

1. K.S. Griffith, L.S. Lewis, S. Mali, and M.E. Parise Treatment of malaria in the United States: a systematic review JAMA 297 2007 2264 2277
2. World Health Organization Guidelines for the Treatment of Malaria 2010 World Health Organization Geneva, Switzerland
3. P. Newton, Y. Suputtamongkol, P. Teja-Isavadharm, S. Pukrittayakamee, V. Navaratnam, I. Bates, et al. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria Antimicrob. Agents Chemother. 44 2000 972 977
4. T.K. Chan, D. Todd, and S.C. Tso Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency BMJ 2 1976 1227 1229
5. M. Chinappi, A. Via, P. Marcatili, and A. Tramontano On the mechanism of chloroquine resistance in Plasmodium falciparum PLoS One 5 2010 e14064
6. G. Gregoriadis Liposomes as a drug delivery system: optimization studies Adv. Exp. Med. Biol. 238 1988 151 159
7. A. Singhal, and C.M. Gupta Antibody-mediated targeting of liposomes to red cells in vivo FEBS Lett. 201 1986 321 326
8. A.K. Agrawal, A. Singhal, and C.M. Gupta Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles Biochem. Biophys. Res. Commun. 148 1987 357 361
9. M. Owais, G.C. Varshney, A. Choudhury, S. Chandra, and C.M. Gupta Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice Antimicrob. Agents Chemother. 39 1995 180 184
10. P. Urbán, J. Estelrich, A. Cortés, and X. Fernàndez-Busquets A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro J. Control. Release 151 2011 202 211
11. D.D. Lasic, and F. Martin Stealth Liposomes 1995 CRC Press, Boca Raton FL, USA
12. P. Urbán, J. Estelrich, A. Adeva, A. Cortés, and X. Fernàndez-Busquets Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors Nanoscale Res. Lett. 6 2011 620
13. A.M. Vaughan, S.H. Kappe, A. Ploss, and S.A. Mikolajczak Development of humanized mouse models to study human malaria parasite infection Future Microbiol. 7 2012 657 665
14. S. Paula, A.G. Volkov, A.N. Van Hoek, T.H. Haines, and D.W. Deamer Permeation of protons, potassium ions, and small polar molecules through phospholipid bilayers as a function of membrane thickness Biophys. J. 70 1996 339 348
15. S. Kyes, P. Horrocks, and C. Newbold Antigenic variation at the infected red cell surface in malaria Annu. Rev. Microbiol. 55 2001 673 707
16. B.M. Cooke, K. Lingelbach, L.H. Bannister, and L. Tilley Protein trafficking in Plasmodium falciparum-infected red blood cells Trends Parasitol. 20 2004 581 589
17. K. Kirk Membrane transport in the malaria-infected erythrocyte Physiol. Rev. 81 2001 495 537
18. J.C. Shillcock, and R. Lipowsky Tension-induced fusion of bilayer membranes and vesicles Nat. Mater. 4 2005 225 228
19. J.J. Wheeler, L. Palmer, M. Ossanlou, I. MacLachlan, R.W. Graham, Y.P. Zhang, et al. Stabilized plasmid-lipid particles: construction and characterization Gene Ther. 6 1999 271 281
20. R.C. MacDonald, R.I. MacDonald, B.P. Menco, K. Takeshita, N.K. Subbarao, and L.R. Hu Small-volume extrusion apparatus for preparation of large, unilamellar vesicles Biochim. Biophys. Acta 1061 1991 297 303
21. G. Stensrud, S. Sande, S. Kristensen, and G. Smistad Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design Int. J. Pharm. 198 2000 213 228
22. H.C. Loughrey, L.S. Choi, P.R. Cullis, and M.B. Bally Optimized procedures for the coupling of proteins to liposomes J. Immunol. Methods 132 1990 25 35
23. S.M. Ansell, P.G. Tardi, and S.S. Buchkowsky 3-(2-Pyridyldithio)propionic acid hydrazide as a cross-linker in the formation of liposome-antibody conjugates Bioconjug. Chem. 7 1996 490 496
24. D.S. Hage Periodate oxidation of antibodies for site-selective immobilization in immunoaffinity chromatography Methods Mol. Biol. 147 2000 69 82
25. N. Maurer, D.B. Fenske, and P.R. Cullis Developments in liposomal drug delivery systems Expert Opin. Biol. Ther. 1 2001 923 947
26. R.C. Switzer III, C.R. Merril, and S. Shifrin A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels Anal. Biochem. 98 1979 231 237
27. S.L. Cranmer, C. Magowan, J. Liang, R.L. Coppel, and B.M. Cooke An alternative to serum for cultivation of Plasmodium falciparum in vitro Trans. R Soc. Trop. Med. Hyg. 91 1997 363 365
28. C. Lambros, and J.P. Vanderberg Synchronization of Plasmodium falciparum erythrocytic stages in culture J. Parasitol. 65 1979 418 420
29. A. Radfar, D. Méndez, C. Moneriz, M. Linares, P. Marín-García, A. Puyet, et al. Synchronous culture of Plasmodium falciparum at high parasitemia levels Nat. Protoc. 4 2009 1899 1915
30. P. Urbán, J.J. Valle-Delgado, N. Mauro, J. Marques, A. Manfredi, M. Rottmann, et al. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium J. Control. Release 177 2014 84 95
31. M. Ramsby, and G. Makowski Differential detergent fractionation of eukaryotic cells Cold Spring Harbor Protocols 2011 http://dx.doi.org/10.1101/pdb.prot5592
32. P.H. O'Farrell High resolution two-dimensional electrophoresis of proteins J. Biol. Chem. 250 1975 4007 4021
33. I. Angulo-Barturen, M.B. Jiménez-Díaz, T. Mulet, J. Rullas, E. Herreros, S. Ferrer, et al. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes PLoS One 3 2008 e2252
34. M.B. Jiménez-Díaz, T. Mulet, V. Gómez, S. Viera, A. Alvarez, H. Garuti, Y. Vázquez, A. Fernández, J. Ibáñez, M. Jiménez, D. Gargallo-Viola, and I. Angulo-Barturen Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence Cytometry 75A 2009 225 235
35. L. Qiu, N. Jing, and Y. Jin Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method Int. J. Pharm. 361 2008 56 63
36. T.D. Madden, P.R. Harrigan, L.C.L. Tai, M.B. Bally, L.D. Mayer, T.E. Redelmeier, et al. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey Chem. Phys. Lipids 53 1990 37 46
37. F. Omodeo-Salè, L. Cortelezzi, N. Basilico, M. Casagrande, A. Sparatore, and D. Taramelli Novel antimalarial aminoquinolines: heme binding and effects on normal or Plasmodium falciparum-parasitized human erythrocytes Antimicrob. Agents Chemother. 53 2009 4339 4344
38. A. Nair, B. Abrahamsson, D.M. Barends, D.W. Groot, S. Kopp, J.E. Polli, et al. Biowaiver monographs for immediate-release solid oral dosage forms: primaquine phosphate J. Pharm. Sci. 101 2012 936 945
39. E. Pachlatko, S. Rusch, A. Müller, A. Hemphill, L. Tilley, E. Hanssen, et al. MAHRP2, an exported protein of Plasmodium falciparum, is an essential component of Maurer's cleft tethers Mol. Microbiol. 77 2010 1136 1152
40. C. Spycher, N. Klonis, T. Spielmann, E. Kump, S. Steiger, L. Tilley, et al. MAHRP-1, a novel Plasmodium falciparum histidine-rich protein, binds ferriprotoporphyrin IX and localizes to the Maurer's clefts J. Biol. Chem. 278 2003 35373 35383
41. L. Tilley, G. McFadden, A. Cowman, and N. Klonis Illuminating Plasmodium falciparum-infected red blood cells Trends Parasitol. 23 2007 268 277
42. C. Spycher, M. Rug, E. Pachlatko, E. Hanssen, D. Ferguson, A.F. Cowman, et al. The Maurer's cleft protein MAHRP1 is essential for trafficking of PfEMP1 to the surface of Plasmodium falciparum-infected erythrocytes Mol. Microbiol. 68 2008 1300 1314
43. J. García, H. Curtidor, O.L. Gil, M. Vanegas, and M.E. Patarroyo A Maurer's cleft-associated Plasmodium falciparum membrane-associated histidine-rich protein peptide specifically interacts with the erythrocyte membrane Biochem. Biophys. Res. Commun. 380 2009 122 126
44. R.J. Howard, S. Uni, M. Aikawa, S.B. Aley, J.H. Leech, A.M. Lew, et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes J. Cell. Biol. 103 1986 1269 1277
45. P.D. Siebert, and M. Fukuda Isolation and characterization of human glycophorin A cDNA clones by a synthetic oligonucleotide approach: nucleotide sequence and mRNA structure Proc. Natl. Acad. Sci. U. S. A. 83 1986 1665 1669
46. M. Fleiner, P. Benzinger, T. Fichert, and U. Massing Studies on protein-liposome coupling using novel thiol-reactive coupling lipids: influence of spacer length and polarity Bioconjug. Chem. 12 2001 470 475
47. K. Maruyama, T. Takizawa, N. Takahashi, T. Tagawa, K. Nagaike, and M. Iwatsuru Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals Adv. Drug Deliv. Rev. 24 1997 235 242
48. P.A. Nygren, M. Eliasson, L. Abrahmsén, M. Uhlén, and E. Palmcrantz Analysis and use of the serum albumin binding domains of streptococcal protein G J. Mol. Recognit. 1 1988 69 74
49. P. Urbán, and X. Fernàndez-Busquets Nanomedicine against malaria Curr. Med. Chem. 21 2014 605 629
50. J. Marques, E. Moles, P. Urbán, R. Prohens, M.A. Busquets, C. Sevrin, et al. Application of heparin as a dual agent with antimalarial and liposome targeting activities towards Plasmodium-infected red blood cells Nanomedicine 10 2014 1719 1728
51. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U. S. A. 88 1991 11460 11464
52. M. Gulati, M. Grover, S. Singh, and M. Singh Lipophilic drug derivatives in liposomes Int. J. Pharm. 165 1998 129 168
53. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
54. V.R. Muzykantov Drug delivery by red blood cells: vascular carriers designed by Mother Nature Expert Opin. Drug Deliv. 7 2010 403 427
55. D.W. Wilson, C. Langer, C.D. Goodman, G.I. McFadden, and J.G. Beeson Defining the timing of action of antimalarial drugs against Plasmodium falciparum Antimicrob. Agents Chemother. 57 2013 1455 1467
56. D.M. Harmening The red blood cell: structure and function Clinical Hematology and Fundamentals of Hemostasis 1996 F. A. Davis Company Philadelphia, PA 54 70
57. A.L. Bailey, and P.R. Cullis Membrane fusion with cationic liposomes: effects of target membrane lipid composition Biochemistry 36 1997 1628 1634
58. S. Mondal Roy, and M. Sarkar Membrane fusion induced by small molecules and ions J. Lipids 2011 2011 528784
59. I.D. Goodyer, B. Pouvelle, T.G. Schneider, D.P. Trelka, and T.F. Taraschi Characterization of macromolecular transport pathways in malaria-infected erythrocytes Mol. Biochem. Parasitol. 87 1997 13 28
60. S. Loew, A. Fahr, and S. May Modeling the release kinetics of poorly water-soluble drug molecules from liposomal nanocarriers J. Drug Deliv. 2011 2011 376548
61. A. Fahr, P.V. Hoogevest, S. May, N. Bergstrand, and S. Leigh Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery Eur. J. Pharm. Sci. 26 2005 251 265
62. H. Kercret, J. Chiovetti, M.W. Fountain, and J.P. Segrest Plasma membrane-mediated leakage of liposomes induced by interaction with murine thymocytic leukemia cells Biochim. Biophys. Acta Biomembr. 733 1983 65 74
63. G. Scherphof, F. Roerdink, M. Waite, and J. Parks Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins Biochim. Biophys. Acta Gen. Subj. 542 1978 296 307
64. J.A. Virtanen, K.H. Cheng, and P. Somerharju Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model Proc. Natl. Acad. Sci. U. S. A. 95 1998 4964 4969
65. I.L. Lisovskaya, I.M. Shcherbachenko, R.I. Volkova, and F.I. Ataullakhanov Clotrimazole enhances lysis of human erythrocytes induced by t-BHP Chem. Biol. Interact. 180 2009 433 439